Cincinnati Children’s

Hippocratic AI specializes in developing large language models focused on safety and patient-facing applications within the healthcare sector. Unlike common approaches that rely heavily on internet data, Hippocratic AI prioritizes acquiring evidence-based healthcare content legally to ensure accurate and reliable information.

STAQ Pharma, Inc. is a Denver-based company that specializes in the manufacture and sale of compounded pharmaceutical medications. Initially known as QualMed Pharmacy, Inc., the company rebranded in 2018 and operates a cGMP-compliant outsourcing facility. STAQ Pharma produces a wide range of compounded medications, including non-sterile and sterile solutions, as well as repackaged sterile medications in prefilled syringes for hospital procedures. The company emphasizes safety, quality, and transparency in its operations, utilizing inventory systems to forecast demand and ensure timely availability of critical products for healthcare facilities. STAQ Pharma aims to enhance access to high-quality compounded medications through its online store and in-house production capabilities.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Enable Injections designs and manufactures wearable devices that deliver injectable drugs directly into the subcutaneous tissue. The system accepts standard vials, syringes, or cartridges, automatically reconstitutes lyophilized solutions, warms the drug, and injects high‑viscosity or high‑volume payloads up to 20 ml. Users place the device on the skin, press a central button, and monitor delivery progress through a viewing window before disposing of the single‑use injector. The company also offers transfer systems for partial or multi‑vial filling and a Bluetooth‑enabled version that can connect to smartphones. Founded in 2010, the company is headquartered in Cincinnati, Ohio, and targets a growing market for self‑administration of biologics and other therapeutics.

Claritas Genomics, Inc. is a genetic diagnostic laboratory based in Cambridge, Massachusetts, specializing in testing and research services for pediatric disorders. Founded in 2012, the company is a subsidiary of The Children's Hospital Corporation and operates in partnership with Boston Children's Hospital. Claritas offers a range of services, including clinical exome analysis, single gene sequencing, and various assay analyses. Its laboratory combines advanced genetic testing technologies with expert clinical interpretation provided by specialists in medical genomics. The aim is to simplify the selection of molecular tests and provide clear, reliable reports that communicate complex genetic information effectively, thereby supporting clinicians in making informed medical decisions.

Assurex Health specializes in personalized medicine, assisting clinicians in determining optimal medications for individual patients with behavioral health and chronic pain conditions. They provide treatment decision support to healthcare providers.

Airway Therapeutics, Inc. is a biopharmaceutical company focused on developing protein therapeutics for lung and pediatric applications. Founded in 2008 and headquartered in Cincinnati, Ohio, with an additional office in Marietta, Georgia, the company is engaged in licensing technology from the pulmonary research program of Cincinnati Children's Hospital Medical Center to enhance its development platform. Airway Therapeutics' key products include recombinant human surfactant protein-D, aimed at preventing bronchopulmonary dysplasia in premature infants, and AT100, a protein replacement therapy for the same condition. The company is dedicated to addressing various market needs related to respiratory and inflammatory diseases by creating innovative biologics that reduce inflammation, lower infection risks, and modulate the immune response, ultimately improving treatment outcomes for patients.

Assurex Health specializes in personalized medicine, assisting clinicians in determining optimal medications for individual patients with behavioral health and chronic pain conditions. They provide treatment decision support to healthcare providers.

QI Healthcare, established in 2012 and headquartered in Cincinnati, Ohio, specializes in developing and providing children’s quality improvement software. The company's flagship product is the Surgical Outcomes Collection System, an application designed to aggregate data from various hospital systems, including Electronic Medical Records (EMR), to perform comprehensive analyses of surgical cases. This analysis helps identify opportunities for enhancing patient care and improving overall outcomes and efficiency within healthcare institutions.